CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,106 enrolled
Drug / intervention
Elective Induction of Laborprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01990612
NCT01990612N/ACompleted
CompareCT.gov

Induction in Nulliparous Women at 39 Weeks to Prevent Adverse Outcomes: A Randomized Controlled Trial

The George Washington University Biostatistics Center·interventional·Posted Nov 21, 2013·Updated Feb 21, 2019

In Brief

A clinical study evaluating Elective Induction of Labor for Labor and Delivery. Completed, enrolled 6,106 participants across 16 sites.

Detailed Summary

A randomized clinical trial to assess whether elective induction of labor at 39 weeks of gestation compared with expectant management will improve outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLabor and Delivery
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 21, 2013
Enrollment StartMar 1, 2014
Primary CompletionNov 1, 2017
Study CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 12.6 years ago

Interventions

Elective Induction of Laborprocedure

Women randomized to induction of labor will undergo induction via oxytocin at 39 weeks 0 days to 39 weeks 4 days. Those with an unfavorable cervix (modified Bishop score \< 5) will first undergo cervical ripening (method left to the discretion of the patient's physician) in conjunction with or followed by oxytocin stimulation unless a contraindication arises.